➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
McKinsey
AstraZeneca
Boehringer Ingelheim
Dow

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

ENBREL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for ENBREL

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Sorrento Therapeutics, Inc.Phase 1
Nova Southeastern UniversityPhase 1
Rochester General HospitalPhase 1

See all ENBREL clinical trials

Recent Litigation for ENBREL

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Pharmacyclics LLC v. Alvogen Pine Brook, LLC2020-03-20
Celgene Corporation v. Mylan Pharmaceuticals Inc.2020-01-02
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC.2019-12-30

See all ENBREL litigation

PTAB Litigation
PetitionerDate
Dr. Reddy's Laboratories, Inc.2018-08-03
2014-11-06
2013-08-15

See all ENBREL litigation

Pharmacology for ENBREL

Company Disclosures: US Patents for ENBREL

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Get Started for $10 Immunex Corporation (Seattle, WA) 2012-03-07 RX Orphan company
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Get Started for $10 Immunex Corporation (Seattle, WA) 2014-02-25 RX Orphan company
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Get Started for $10 Immunex Corporation (Seattle, WA) 2009-09-05 RX Orphan company
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Get Started for $10 Immunex Corporation (Seattle, WA) 2009-09-11 RX Orphan company
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Get Started for $10 2009-09-05 RX Orphan company
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Get Started for $10 Immunex Corporation (Seattle, WA) 2009-09-05 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for ENBREL

These patents were identified by searching patent claims

Supplementary Protection Certificates for ENBREL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1090038-9 Sweden   Get Started for $10 PRODUCT NAME: DENOSUMAB
591 Finland   Get Started for $10
PA2017038,C2041177 Lithuania   Get Started for $10 PRODUCT NAME: SARILUMABAS; REGISTRATION NO/DATE: EU/1/17/1196 20170623
C300008 Netherlands   Get Started for $10 PRODUCT: ETANERCEPTUM
C 2015 016 Romania   Get Started for $10 PRODUCT NAME: IBRUTINIB SAU O SARE FARMACEUTIC ACCEPTABILA A ACESTUIA; NATIONAL AUTHORISATION NUMBER: EU/1/14/945; DATE OF NATIONAL AUTHORISATION: 20141021; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/14/945; DATE OF FIRST AUTHORISATION IN EEA: 20141021
2090010-6 Sweden   Get Started for $10 PRODUCT NAME: UPADACITINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/19/1404 20191218
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Baxter
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.